🇺🇸 FDA
Patent

US 7229995

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

granted A61PA61P1/04A61P1/12

Quick answer

US patent 7229995 (Gonadotropin-releasing hormone receptor antagonists and methods relating thereto) held by Neurocrine Biosciences, Inc. expires Mon Jun 07 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Jun 12 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 07 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P1/04, A61P1/12, A61P13/08, A61P15/00